22.04.2016 • News

Valtris Acquires Akcros Chemicals

Valtris Specialty Chemicals, a portfolio company of private equity firm H.I.G. Capital, has acquired specialty chemicals company Akcros Holdings. Financial terms were not disclosed. Akcros is a provider of specialty chemicals used as additives in the production and processing polymers, paints and coatings with operations in Europe and North America. The company has two primary manufacturing sites in Eccles, UK, and New Brunswick, New Jersey, USA, with additional production capacity in Mumbai, India, and Guangzhou, China.

Paul Angus, CEO of Valtris, said Akcros is a highly strategic and complementary acquisition, providing new and multiple avenues for growth. “In addition, Valtris will now be a leading player not only in North America but also in Europe, a major goal of ours,” he said.

Valtris was carved out of Ferro by H.I.G. in December 2014. Akcros is the eleventh acquisition that H.I.G. has completed in the chemicals sector since 2008, and the fourth in the last two years.

Virtual Event

Outsourced Biomanufacturing
Strategic Outsourcing in Biopharmaceuticals

Outsourced Biomanufacturing

April 22, 2026 | Join biopharma professionals, CDMO leaders, and supply chain innovators for a virtual event exploring the future of outsourced biomanufacturing.

Interview

Navigating Uncertainty and Driving Innovation
Meeting Pharma’s Demand for Speed, Reliability, and Flexibility

Navigating Uncertainty and Driving Innovation

Axplora CCO Arul Ramadurai discusses navigating industry uncertainty, building strategic partnerships, and advancing flexible pharmaceutical manufacturing

most read